Michelle Welch+FollowAstraZeneca’s Tagrisso Combo: 4-Year Survival!AstraZeneca just dropped some jaw-dropping lung cancer trial results: their Tagrisso + chemo combo is helping patients live nearly four years—almost a year longer than Tagrisso alone! The combo slashed the risk of death by 23%, and nearly half the patients made it to four years. Side effects? Manageable, mostly from chemo. Tagrisso’s already a global superstar, and this just cements its place as a game-changer for EGFR-mutated lung cancer. Plus, AstraZeneca’s sales and stock are soaring. Huge win for patients and investors! #Health #BodyHealth #AstraZeneca20Share
Jacqueline Howard DDS+FollowAstraZeneca’s Cancer Drug Scores Big!AstraZeneca just dropped some major news—its cancer drug Imfinzi, when paired with standard therapy, helped high-risk bladder cancer patients stay cancer-free longer! No new safety issues popped up, and patients could stick with their treatments. Imfinzi’s already a big deal for other cancers, but this new data could mean even more approvals. No wonder AZN stock is getting a little love today! Anyone else watching this stock now? #AstraZeneca #Imfinzi #CancerResearch #Biotech #StockMarket #Health252Share
Stacy Fisher+FollowNew Pill Cuts Cholesterol, No Fasting Needed!AstraZeneca's new once-daily pill, AZD0780, is a game-changer for those battling high cholesterol. It slashes "bad" cholesterol by over 50% when combined with statins, and most patients hit optimal levels! Unlike Merck’s version, it doesn’t require fasting—finally, an easier solution! 🌟 #HealthNews #Cholesterol #AstraZeneca #Health10211Share
